#RivaaraLabs acknowledges the incredible influence of communities in shaping the HIV response and global health.
Let's unite under the theme 'Let communities lead.' Reflecting on progress, awareness & commitment for a world without AIDS by 2030.
#WorldAIDSDay#CommunityImpact
We are grateful for the chance to participate in the CRITIC – South Zone Critical Care Conference 2023, by ISCCM – Hyderabad on November 18th & 19th, 2023.
We cordially invite you all to meet us at stall no.30 and be a part of this grand event.
#RivaaraLabs#ISCCM#CriticalCare
COPD is one the highly under diagnosed disease. Late diagnosis of COPD leads to a significant direct and indirect cost. Late diagnosis of COPD is also associated with a higher exacerbation rate, and a lot of comorbidities.
#rivaaralabs#copd#copdawareness
We had a pleasure of participating in 11th Conference at EZCCCON - Eastern Zonal Critical Care (ISCCM Guwahati branch) held on 4th & 5th Nov23 at Guwahati at Maniram Deewan Trade Center.
#ezcccon#isccm#isccmcriticare#rivaaralabs
Pneumonia is an infection of the lungs. Treatment depends largely on proper pathogen identification and precise recognition of antibiotic resistance to individualize the treatment and improved healthcare outcomes.
#rivaaralabs#WorldPneumoniaDay#StopPneumonia
Rivaara Labs wishes you and your loved ones a Diwali filled with joy, well-being, and moments of togetherness.
Happy Diwali!
#rivaaralabs#diwali#HappyDiwali
On World Sepsis Day, Rivaara Labs reaffirms its dedication to reducing the incidence and mortality due to sepsis in India. Through its distinct syndromic Sepsis and AMR panel, we empowers clinicians to pinpoint the exact pathogen in less than 24 hrs.
#worldsepsisday#rivaaralabs
In healthcare epidemiology and #antimicrobialstewardship,
improvement of antimicrobial use requires healthcare provider behavior change.
https://t.co/eQIQEzkG7G
The more we know about antibiotic resistance, the more new missing pieces are detected.
One such missing piece not always taken in enough consideration is that the problem for human health is not #AntibioticResistance, but infection.
🔗https://t.co/93TMbp2z3R
#RivaaraLabs
At #RivaaraLabs we believe in fostering an inclusive culture by encouraging each one to bring their ‘whole self’ to work.
Meet Shalini, our Research Scientist in the New Product Development team! This is her story of how valued she feels every day.
🔗 https://t.co/CptqlM7A3d
Human Papilloma Virus (#HPV) molecular tests perform better than alternative screening methods – such as pap smear and visual inspection with acetic acid (VIA), e.g. helping identify more patients who are in need of treatment.
#CervicalCancer#MolecularDiagnostics#RivaaraLabs
Data shows that #CervicalCancer is the second most common cancer in India in women accounting for 18.3% of all cancer cases in women. To end cervical cancer, 7 out of 10 women should be screened by 35 years old.
🔗 https://t.co/6Gy1js7x4O
#RivaaraLabs#MolecularDiagnostics
"Up to 70% of antibiotic courses prescribed at discharge could be improved through narrowing antibiotic spectrum, proper dosing, reducing duration or stopping antibiotics altogether."
🔗 https://t.co/bqABQPV0Qr
#Antibiotics#RivaaraLabs#MolecularDiagnostics
Happy Independence Day, India! 🇮🇳
We celebrate what makes India soar as the nation progresses to become the Aatmanirbhar and Swasth Bharat.
#India#IndependenceDay
27 new antibiotics are in the clinical trial stage of drug development, and only six are considered innovative enough to overcome antibiotic resistance. To know more https://t.co/uGPir1bxv4
#Antibiotics#AntibioticResistance#rivaaralabs
#RivaaraLabs is now in Guwahati!
We will be the first #MolecularDiagnostics lab in Assam with an exclusive focus on infectious diseases.
With a dedicated scientific team, we are committed to offer faster and accurate results to hospitals and clinicians, benefiting the patients.
#AntibioticResistance (ABR) is currently one of the most urgent threats to global health.
Countries with high quality health systems were associated with low levels of #antibiotic resistance among all the gram-negative bacteria investigated.
#RivaaraLabs
https://t.co/emwDIaj27Q